Join us for a discussion on the latest FDA-approved anti-amyloid treatments. Alzheimer’s Association Senior Director of Scientific Engagement Dr. Rebecca Edelmayer and Indiana University Alzheimer’s researcher and professor Dr. Liana Apostolova will discuss how the new drugs are administered, what they are designed to do and next steps around access to them. This webinar series is supported by Procter & Gamble.
Learn more about ALZ Talks: https://alz.org/alztalks.
ADDITIONAL RESOURCES
Find more information on current treatments at https://alz.org/alzheimers-dementia/treatments
Connect with our 24/7 Helpline at 800.272.3900. Specialists and master’s-level clinicians offer free, confidential support and information to people living with dementia, caregivers, families and the public.
Get in touch with your local chapter at https://alz.org/chapters to learn more about volunteer opportunities and available support.
Find online education about Alzheimer’s, caregiving, managing money, healthy living, and more: https://alz.org/education.
Local resources and support can also be found at https://alz.org/crf and you can connect with others by visiting our free online community, https://alzconnected.org.
See the Alzheimer’s Disease Facts and Figures: https://alz.org/facts.
ALZHEIMER’S ASSOCIATION ON SOCIAL
Facebook: https://www.facebook.com/ActionAlz
Twitter: https://www.twitter.com/AlzAssociation
Instagram: https://www.instagram.com/AlzAssociation
YouTube: https://www.youtube.com/ActionAlz
Subscribe to the Alzheimer’s Association on YouTube: https://bit.ly/3at9a0A
#ALZTalks #AlzheimersAssociation #AlzheimersDisease #AlzheimersTreatments
